The Weekly Litigation News Digest is now live. Subscribe now

A New Use For Deferiprone - EP1294379

The patent EP1294379 was granted to Apotex on Apr 1, 2009. The application was originally filed on Jun 28, 2001 under application number EP01949158A. The patent is currently recorded with a legal status of "Revoked".

EP1294379

APOTEX
Application Number
EP01949158A
Filing Date
Jun 28, 2001
Status
Revoked
May 14, 2021
Publication Date
Apr 1, 2009
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LIPOMEDFeb 11, 2020CIESLAINTERVENTION ADMISSIBLE
LIPOMEDDec 24, 2009CIESLAADMISSIBLE

Patent Citations (1) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTGB2118176

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents